Quality Management BPI - New Contract
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $13,000,000 to $20,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 561990 All Other Support Services
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new Quality Management Business Process Improvement (BPI) contract to support ongoing operations. The solicitation is expected to be released on January 1, 2026, with an estimated award date of September 1, 2026. This new contract will replace the current contract expiring in September 2026 and is structured as a base year plus four option years.
The estimated contract value is approximately $15 million annually, with a total range of $13 million to $20 million across the contract period. The FDA plans to allocate $1.5 million per year from MDUFA V operational funds toward this contract. Interested vendors should direct inquiries to the FDA's Contracting and Disposition Resources Acquisitions mailbox at cdriacquisitions@fda.hhs.gov. This procurement falls under NAICS code 561990 (All Other Support Services) and is not designated as a set-aside contract.
Forecast text
Current Contract expires Sept 2026. It is QMOE's intent to request approval for a new contract in place at that time, base + 4 years. Planning to use QMOE's 1.5 million per year MDUFA V operational funds to cover part of the contract. We expect the contract to be approx. 15M (1 base year + 4 option years, per year).
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast